*** CHEMICAL IDENTIFICATION ***
RTECS NUMBER : KF5887600
CHEMICAL NAME : 1-165-Erythropoietin (human clone lambda HEPOFL13
protein moiety), glycoform beta
CAS REGISTRY NUMBER : 122312-54-3
LAST UPDATED : 199506
DATA ITEMS CITED : 9
COMPOUND DESCRIPTOR : Drug
SYNONYMS/TRADE NAMES :
* Epoch
* Epoetin Beta
* Epoetin-beta (genetical recombination)
* Marogen
*** HEALTH HAZARD DATA ***
** ACUTE TOXICITY DATA **
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : >230 ku/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 21,319,1990
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : >23 ku/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 21,319,1990
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : >23 ku/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 21,319,1990
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : >230 ku/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 21,319,1990
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : >23 ku/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 21,319,1990
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : >23 ku/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 21,319,1990
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Mammal - dog
DOSE/DURATION : >23000 iu/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu
Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972-
Volume(issue)/page/year: 22,1249,1994
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Mammal - dog
DOSE/DURATION : >23 ku/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 21,319,1990
** OTHER MULTIPLE DOSE TOXICITY DATA **
TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 4800 iu/kg/4W-I
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - retinal changes (pigmentary
depositions, retinitis, other)
Blood - change in clotting factors
Blood - changes in platelet count
REFERENCE :
YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu
Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972-
Volume(issue)/page/year: 22,1331,1994
*** END OF RECORD ***
|
|
|
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
| NAME | CAS |
Erythromycin,9-deoxo-9-(((2-methylphenyl)sulfonyl)amino)-, (9S)-
| 61066-22-6 |
Erythromycin,9-deoxo-9-(((4-methylphenyl)sulfonyl)amino)-, (9S)-
| 56998-46-0 |
Erythromycin,9-deoxo-9-(((4-((1-oxopropyl)amino)phenyl)sulfonyl)amino)-, (9S)-
| 61066-21-5 |
Erythromycin, 12-deoxy-
| 527-75-3 |
Erythromycin,1,4-dihydro-1-ethyl-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylate
| 167029-45-0 |
Erythromycin, 2'-ester withN-(2-mercaptopropionyl)glycine 2-thiophenecarboxylate
| 167029-45-0 |
Erythromycin, 8-fluoro-
| 82664-20-8 |
Erythromycin, 2'-(2-furancarboxylate)
| 60847-79-2 |
Erythromycin, 2'-(3-(2-furyl)acrylate)
| 60847-78-1 |
2,7-(Epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2H)-dione, 3-formyl-5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, 21-acetate, O-heptyloxime
| 41776-57-2 |
Erythromycin, glucoheptonate (11)
| 23067-13-2 |
Erythromycin, hydrochloride
| 14271-02-4 |
Erythromycin, 9-O-((2-methoxyethoxy)methyl)oxime
| 80214-83-1 |
Erythromycin, 6-O-methyl-
| 81103-11-9 |
Erythromycin, 2'-(5-nitro-2-furancarboxylate)
| 60847-76-9 |
Erythromycin, 2'-((5-nitro-2-furyl)acrylate)
| 60847-77-0 |
Erythromycin palmitate
| 111639-04-4 |
Erythromycin, d-pantothenate
| 111639-04-4 |
Erythromycin, 2'-propionate
| 134-36-1 |
Erythromycin, propionate (ester), compd. withmonododecyl sulfate (1:1)
| 3521-62-8 |
2,7-(Epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2H)-dione, 3-formyl-5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, 21-acetate, O-(hept-2-yl) oxime
| 41776-73-2 |
Erythromycin, stearate (salt)
| 643-22-1 |
Erythromycin, sulfamate (salt)
| 24380-21-0 |
Erythronic acid, 4-(6-amino-9H-purin-9-yl)-4-deoxy-,D-
| 23918-98-1 |
Erythropalum populifolium (Arn.)Mast., extractSUBSTANCE DEFINITION :Plant belonging to the family OlacaceaeREFERENCE :IJEBA6 Indian Journal of Experimental Biology. (Publications & InformationDirectorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963-Volume(issue)/page/year: 28,619,1990
| 23918-98-1 |
Erythrophleum guineense (leaves)SUBSTANCE DEFINITION :Leaves of large trees belonging to the family CaesalpinaceaeREFERENCE :RVTSA9 Research in Veterinary Science. (British Veterinary Assoc., 7Mansfield St., London W1M OAT, UK) V.1- 1960- Volume(issue)/page/year:28,112,1980
| 23918-98-1 |
Erythropoietin
| 11096-26-7 |
1-165-Erythropoietin (human clone lambda HEPOFL13protein moiety), glycoform alpha
| 113427-24-0 |
1-165-Erythropoietin (human clone lambda HEPOFL13protein moiety), glycoform beta
| 122312-54-3 |
1-165-Erythropoietin (human clone lambda hepofl13protein moity), glycoform-gamma
| 130455-76-4 |
D-Erythrose, tri-O-acetyl-, p-nitrophenylhydrazine
| 54420-06-3 |
2,7-(Epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2H)-dione, 3-formyl-5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, 21-acetate, O-(hept-3-yl) oxime
| 41887-57-4 |
Erythroxylum kunthianum Kurz, extract excluding rootSUBSTANCE DEFINITION :Indian plant belonging to the family ErythroxylaceaeREFERENCE :IJEBA6 Indian Journal of Experimental Biology. (Publications & InformationDirectorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963-Volume(issue)/page/year: 26,883,1988
| 41887-57-4 |
Escin
| 6805-41-0 |
alpha-Escin
| 66795-86-6 |
beta-Escin
| 11072-93-8 |
beta-Escin, monosodium salt
| 64156-26-9 |
Escin, sodium salt
| 20977-05-3 |
Escin, triethanolamine salt
| 102505-08-8 |
Espinomycin B
| 102534-94-1 |
Essential phospholipidsSUBSTANCE DEFINITION :Chemically defined as diglyceride esters of choline phosphoric acid with apredominant content of unsaturated fatty acidsREFERENCE :OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180,Sendai 980-91, Japan) V.1- 1967-
| 102534-94-1 |
Estra-1,4-diene-3,17-dione, 10-hydroxy-
| 549-03-1 |
2,7-(Epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2H)-dione, 3-formyl-5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, 21-acetate, O-(hex-2-enyl) oxime
| 63950-95-8 |
Estra-1,4-diene-3,17-dione, 10-hydroxy-, acetate
| 4147-12-0 |
Estra-1,4-dien-3-one, 10-beta-chloro-17-beta-hydroxy-
| 4147-12-0 |
Estra-1,4-dien-3-one, 10,17-beta-dihydroxy-,10-acetate
| 4147-11-9 |
Estra-1,4-dien-3-one, 10,19-dihydroxy-, 10-acetate
| 4147-11-9 |
Estra-4,9-dien-3-one,11-(4-(dimethylamino)phenyl)-17-hydroxy-17-(3-hydroxy-1-propenyl)-, (11-beta,17-beta,17(Z))-
| 97747-88-1 |
Estra-4,9-dien-3-one,11-(4-(dimethylamino)phenyl)-17-hydroxy-17-(3-hydroxypropyl)-, (11-beta,13-alpha,17-alpha)-
| 96346-61-1 |
Estra-4,9-dien-3-one,11-(4-(dimethylamino)phenyl)-17-hydroxy-17-(1-propynyl)-, (11-beta, 17-beta)-
| 84371-65-3 |
|
|